The American Society of Regional Anesthesia and Pain Medicine has published a practice advisory on local anesthetic systemic toxicity (LAST) called “Guidelines for the Management of Severe Local ...

Our results suggest that ultrasound guidance, HBV infection and the female sex are risk factors of LAST in LPBs and SNBs. For patients infected with HBV or female patients undergoing LPBs and SNBs, ...

Over the last decade, poisonings and deaths linked to the use of local anesthetics have decreased. Even so, poisonings from one commonly used anesthetic, lidocaine, have increased in the United States ...

If a drug is super potent, the prescribed dose can give you more of the drug than is necessary or safe. With lidocaine, as the Teligent-written, FDA-posted recall notice states, that can lead to ...

There was a decrease noted in reports of death in the operating room, from 47% before 2010 to 15% after 2010 in a case analysis. HealthDay News — Local anesthetic poisoning reports decreased following ...

Teligent Pharma has voluntarily recalled two lots of Lidocaine HCl Topical Solution USP 4% because testing found it to be “super potent.” People could be using a higher than intended dose of the ...

For the second time in just over six weeks, Teligent Pharma recalled Lidocaine HCl Topical Solution 4%, 50ml for super potency. This time, instead of just one lot, Teligent pulled five lots, four ...

An impressive new study, led by scientists from the Boston Children's Hospital, has developed a novel method to tame one of the world's most potent toxins, tetrodotoxin, commonly found in the ...

Teligent Pharma has announced a new recall that impacts its Lidocaine HCl Topical Solution USP 4% anesthetic liquid sold in 50ml glass bottles. The reason, the company explains, is the potential for ...

One lot of Lidocaine HCl Topical Solution 4%, 50ml has been recalled by Teligent Pharma after company-testing found it to be super potent. As the Teligent-written, FDA-posted recall notice states, ...